NVO vs SOLV
NVO (NVO) versus Solventum Corp. (SOLV) — a side-by-side from cached financials, not a winner call.
NVO (NVO) common stock.
Solventum Corp. (SOLV) is a medical instruments & supplies company listed on NYSE.
NVO does not have a complete income-statement cache yet.
Latest reported SOLV revenue for 2025-12-31 was $8.32B. Net income was $1.56B. Revenue was up 0.9% from 2024-12-31 to 2025-12-31. SOLV currently screens at market cap $12.91B and trailing P/E 9.1.
NVO currently screens at market cap $0. SOLV currently screens at market cap $12.91B and trailing P/E 9.1.
Not investment advice. Open the NVO and SOLV stock pages for the full models.
Not investment advice.